Pharmaceutical PV DIV - FSB

The Defense Logistics Agency awarded a $13,822.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued without set-aside designation on January 26, 2026, is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the Defense Logistics Agency's $30.3 billion pharmaceutical acquisition strategy. The company supplies a comprehensive range of pharmaceutical products to support Department of Defense military healthcare operations globally, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals.

DMS Pharmaceutical Group's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, contraceptive devices, vaccines, and routine pharmaceuticals spanning antibiotics, antivirals, pain management drugs, and other medical consumables. The contractor has demonstrated substantial federal contracting capability through numerous delivery orders under the PPV-G GEN V program, with awards ranging from under $100 to over $115,000. As the sole awardee identified in this delivery order documentation with no subcontractor relationships noted, DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status and established performance record to compete effectively in Department of Defense procurement while maintaining consistent contract performance across multiple therapeutic categories and product lines.